// company-profile
Entrada Therapeutics, Inc.
TRDA// activity-summary
Recent insider activity is bullish. Over the last 30 days, 6 insiders purchased shares. Buying was led by Zeiher Bernhardt G.
// 90-day insight
Over the last 90 days, Entrada Therapeutics, Inc. insiders bought $29K across 7 transactions with no open-market sales.
- Most active insider: Dowden Nathan J with 3 transactions totaling $256K.
- Largest single sale: $399K by Sethuraman Natarajan on May 4, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Entrada Therapeutics, Inc. as of 2026-03-31
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Zeiher Bernhardt G | TRDA | Award | 19,000 | $0.00 | $0K |
| Jun 10, 2026 | Chapman Gina | TRDA | Award | 19,000 | $0.00 | $0K |
| Jun 10, 2026 | PARMAR KUSH | TRDA | Award | 19,000 | $0.00 | $0K |
| Jun 10, 2026 | Thistle Mary | TRDA | Award | 19,000 | $0.00 | $0K |
| Jun 10, 2026 | Radhakrishnan Maha | TRDA | Award | 19,000 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.